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Periodontitis induced by bacterial infection exacerbates
features of Alzheimer’s disease in transgenic mice
Naoyuki Ishida1,2,3, Yuichi Ishihara1, Kazuto Ishida4, Hiroyuki Tada3, Yoshiko Funaki-Kato1,2,3, Makoto Hagiwara3, Taslima Ferdous5,
Mohammad Abdullah5, Akio Mitani2, Makoto Michikawa5 and Kenji Matsushita3
Periodontitis is a localized infectious disease caused by periodontopathic bacteria, such as Porphyromonas gingivalis. Recently, it has
been suggested that bacterial infections may contribute to the onset and the progression of Alzheimer’s disease (AD). However, we
do not have any evidence about a causative relationship between periodontitis and AD. In this study, we investigated by using a
transgenic mouse model of AD whether periodontitis evoked by P. gingivalis modulates the pathological features of AD. Cognitive
function was significantly impaired in periodontitis-induced APP-Tg mice, compared to that in control APP-Tg mice. Levels of
Amiloid β (Aβ) deposition, Aβ40, and Aβ42 in both the hippocampus and cortex were higher in inoculated APP-Tg mice than in
control APP-Tg mice. Furthermore, levels of IL-1β and TNF-α in the brain were higher in inoculated mice than in control mice. The
levels of LPS were increased in the serum and brain of P. gingivalis-inoculated mice. P. gingivalis LPS-induced production of Aβ40
and Aβ42 in neural cell cultures and strongly enhanced TNF-α and IL-1β production in a culture of microglial cells primed with Aβ.
Periodontitis evoked by P. gingivalis may exacerbate brain Aβ deposition, leading to enhanced cognitive impairments, by a
mechanism that involves triggering brain inflammation.
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INTRODUCTION
Periodontitis is a chronic inflammatory disorder in the oral cavity
that causes destruction of supportive tissues including the alveolar
bone around teeth, finally leading to tooth loss. A resident biofilm,
so-called dental plaque, that forms in subgingival pockets evokes
chronic inflammation in periodontal tissues and causes alveolar
bone loss.1 Periodontitis develops due to the interaction between
periodontal pathogenic bacteria and the host. One of the
important periodontal pathogens, Porphyromonas gingivalis, is
strongly involved in the onset and progression of periodontitis. P.
gingivalis and its toxins, such as lipopolysaccharide (LPS) induce
the production of proinflammatory cytokines and chemokines and
promote inflammation in periodontal tissues. Studies have shown
possible links between periodontitis and diseases including
diabetes,2,3 atherosclerosis,4,5 osteoporosis,6 coronary heart dis-
ease,7,8 and Alzheimer’s disease (AD).9–13 Results of studies have
shown intravascular infiltration of periodontitis-related bacteria
and their spread to target organs, but the mechanisms by which
the bacteria cause diseases are not fully understood.
AD is a brain disorder that affects a region of the brain that
controls cognitive function and memory. In the initial stage of this
disease, recent memory is affected, but long-term memory,
learning, decision and communication capabilities are also
gradually affected as the disease progresses.14,15 Lines of evidence
have suggested that AD is caused by accumulation of amyloid β
peptide (Aβ), leading to tauopathy accompanied by synaptic
dysfunction and intracerebral inflammation, which is assumed to
be caused by Aβ deposits.16–18 Although it has been reported that
long-term administration of nonsteroidal anti-inflammatory drugs
can prevent the occurrence of neurodegenerative diseases,19 it
has been claimed in some reports that there is no such effect.20 In
the immune response in the central nervous system, microglia
play a central role.21 Microglia function in the elimination of waste
products that have accumulated in the brain. These cells also
produce cytokines, such as interleukin (IL)-1β, IL-6, and tumor
necrosis factor-α (TNF-α), and reactive oxygen species, and they
induce neurodegeneration in AD, indicating the possibility that
they promote.21,22
It is possible that chronic inflammation that has developed in
peripheral organs exacerbates the pathology of AD, and one of
such chronic inflammatory diseases is periodontitis. Periodontal
pathogenic bacteria spread throughout the body via blood vessels
and airways. In addition, it is believed that inflammatory
mediators, such as cytokines produced in periodontal tissues are
carried to target organs in a hematogenous manner, exacerbating
the inflammatory response in the organs.23 nterestingly, P.
gingivalis is frequently detected in autopsied brain tissue of AD
patients.24 These findings suggest that periodontal pathogenic
bacteria may exacerbate the pathology of AD. In addition, several
studies have shown correlations of periodontal diseases with
cognitive function and AD.9–13 However, the molecular mechan-
ism by which periodontitis is involved in AD pathogenesis has not
been clarified.
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In this study, we induced experimental periodontitis by P.
gingivalis infection in the oral cavity of amyloid precursor protein
(APP) transgenic mice and examined the effect of periodontitis on
pathophysiology of AD in those mice.
RESULTS
Development of periodontitis by P. gingivalis infection in APP-Tg
mice
To develop experimental periodontitis in APP-Tg mice, we
inoculated the mice with P. ginigivalis ATCC 33,277 mixed with
carboxymethyl cellulose, which was delivered orally. After 5 weeks,
we evaluated alveolar bone loss in the mice. As shown in Fig. 1, P.
gingivalis-infected mice displayed significantly increased alveolar
bone loss compared with that in control mice, as indicated by a
decrease in relative amounts of bone around mandibular molars
of infected mice. Alveolar bone resorption in the mesial side and
furcation area of the μm2, the level of Aβ deposition was increased
in the hippocampus of P. gingivalis-infected mice (19,182.2 ±
7334.9 μm2) (P = 0.0028, F = 0.82). The Aβ deposition area in the
cortex in the P. gingivalis-infected group (4263.8 ± 3257.2 μm2)
was larger than that in the control group (2658.2 ± 1312.6 μm2)
but these values were not significantly different (P = 0.23, F =
0.041) (Fig. 2).
We next examined the concentrations of Aβ in the brains from
P. gingivalis-infected APP-Tg mice. As shown in Fig. 3c, the brain
levels of Aβ40 and Aβ42 in P. gingivalis-inoculated mice than in
control mice. Production levels of Aβ40 and Aβ42 in the
hippocampus in the control group were 24.8 ± 8.5, and 209.8 ±
77.1 ng/μg protein, respectively. On the other hand, those levels in
the hippocampus in the P. gingivalis-infected group were 35.4 ±
13.1 and 307.1 ± 99.7 ng/μg protein, respectively. The values were
significantly different (Aβ40: P = 0.047, F = 0.21; Aβ42: P = 0.025, F
= 0.45) between the groups. Aβ40 and 42 production levels in the
cortex in the control group were 6.16 ± 2.3 and 52.5 ± 27.6 ng/μg
protein, respectively, and the levels in the cortex in the P.
gingivalis-infected group were 11.4 ± 5.7 and 84.3 ± 33.1 ng/μg
protein, respectively. The values were also significantly different
(Aβ40: P = 0.011, F = 0.01; Aβ42: P = 0.031, F = 0.62) between the
groups.
AD is caused by accumulation of Aβ due to intracerebral
inflammation, and increased levels of proinflammatory cytokines,
such as TNF-α and IL-1β were shown in AD patients. Therefore, we
examined whether P. gingivalis infection affects the levels of TNF-α
and IL-1β in the brains of APP-Tg mice. Quantification using ELISA
showed that the brain levels of IL-1β and TNF-α were higher in the
P. gingivalis-inoculated mice than in the control mice (IL-1β: 17.5 ±
2.3 μg/ml vs. 14.4 ± 2.6 μg/ml, P = 0.0062, F = 0.66; TNF-α: 60.2 ±
2.8 μg/ml vs. 57.3 ± 2.2 μg/ml, P = 0.016, F = 0.51) (Fig. 3d).
Endotoxin concentrations in the brain and serum of P. gingivalis-
infected APP-Tg mice
We then examined the mechanism by which P. gingivalis infection
enhanced brain inflammation. A recent study showed that P.
gingivalis and its LPS were found at a high frequency in autopsied
brain tissues of patients who died of AD; however, they were not
found in normal human brain tissues. Therefore, we measured the
concentrations of bacterial LPS in the sera and brains of P.
gingivalis-inoculated APP-Tg mice. As shown in Fig. 4, although
endotoxin was detected even in the sera and brains of control
mice (3.51 ± 0.74 EU/ml and 0.05 ± 0.03 EU/ml, respectively), the
levels were increased in the sera and brains of P. gingivalis-
inoculated mice (4.54 ± 0.88 EU/ml and 0.12 ± 0.06 EU/ml, respec-
tively) and the values were different (Sera: P = 0.033, F = 0.74;
Brains: P = 0.022, F = 0.2).
Induction of Aβ by stimulation with P. gingivalis LPS in neuronal
cell cultures
To try to examine the mechanism by which P. gingivalis LPS
enhances brain inflammation, we examined whether P. gingivalis
LPS induces Aβ production in murine neuronal cell cultures. As
shown in Fig. 5, Aβ40 and Aβ42 production levels were increased
in the media in neuronal cell cultures stimulated with 1.0 (105.9 ±
3.4 pmol/L vs. 151.9 ± 3.4 pmol/L; P= 0.002, F = 0.084) and 10.0 µg/ml
(105.9 ± 3.4 pmol/L vs. 152.3 ± 5.0 pmol/L; P = 0.00052, F = 0.65) of
P. gingivalis LPS.
Effect of P. gingivalis LPS on Aβ-induced cytokine production in
microglia cell cultures
Aβ oligomers induce overproduction of proinflammatory cyto-
kines, such as TNF-α and IL-1β. To determine the effects of P.
gingivalis LPS on Aβ42-induced inflammatory responses in
microglia, various concentrations of P. gingivalis LPS were added
to microglial cell cultures primed with fibrillized Aβ42, and protein
levels of TNF-α and IL-1β in the media were measured by ELISA.
Small amounts of TNF-α were induced in the media from
microglial cells primed by 10 µM Aβ42 and by stimulation with
0.01–1.0 µg/ml P. gingivalis LPS. However, by stimulation with
0.1–1.0 µg/ml P. gingivalis LPS, the production of TNF-α was
significantly increased in the media from Aβ 42-primed microglia
(Aβ42: 48.4 ± 18.5 pg/ml vs. Aβ42 + 0.1 µg/ml LPS: 162.6 ± 12.0 pg/ml,
Fig. 1 Evaluation of alveolar bone loss in P. gingivalis-infected APP-
Tg mice. a Alveolar bone resorption (imaged by µ-CT). Control: Mice
inoculated with CMC alone, P. gingivalis: Mice inoculated with CMC
and P. gingivalis. b Alveolar bone resorption was evaluated in the
furcation and mesial side of the second molar mandible. Results are
expressed as means± S.D., **p< 0.01, ***p< 0.001
Fig. 2 Evaluation of cognitive function in P. gingivalis-infected APP-
Tg mice. Results are expressed as means± S.D., *p< 0.05, ***p<
0.001
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P = 0.0038, F = 0.51; Aβ42: 48.4 ± 18.5 pg/ml vs. Aβ42 + 1.0 µg/ml
LPS: 355.7 ± 10.9 pg/ml, P = 0.0012, F = 0.54) (Fig. 6). On the
other hand, IL-1β production was not induced in the media in
Aβ42-primed microglial cell cultures. However, 1.0 μg/ml of LPS
stimulation significantly enhanced IL-1β production in Aβ42-
primed microglial cell cultures (LPS: 7.5 ± 2.3 pg/ml vs. LPS + Aβ42:
59.5 ± 12.3 pg/ml, P = 0.037, F = 0.28). These results suggest that
P. gingivalis LPS may exacerbate brain inflammation in AD by
activating microglia cooperatively with Aβ.
DISCUSSION
Recent epidemiological evidence has shown that periodontitis
and its causative bacteria may also be associated with AD.
However, these causative relationships have not been shown. In
the present study, we demonstrated for the first time that
periodontitis, caused by P. gingivalis infection, exacerbates the
pathological features of AD in a murine model.
How does P. gingivalis infection exacerbate the pathological
features of AD? Chronic inflammation in the brain is thought to
Fig. 3 Amyloid plaque deposition in the cortex and hippocampus of APP-Tg mice. a Immunostaining of Aβ in brain sections. b Aβ loads in
brain sections. Results are expressed as means± S.D., **p< 0.01. c Aβ40 and Aβ42 in the cortex and hippocampus of P. gingivalis-infected APP-
Tg mice. Concentrations of Aβ40 and Aβ42 in the extracts of brain were measured by ELISA. Control: Mice inoculated with CMC alone, P.
gingivalis: Mice inoculated with CMC and P. gingivalis. Results are expressed as means± S.D., *p< 0.05. d TNF-α and IL-1β in the brain in P.
gingivalis-infected APP-Tg mice. Amounts of TNF-α and IL-1β in brain extracts were measured by ELISA. Results are expressed as means± S.D.,
*p< 0.05, **p< 0.01
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play an important role in the etiology of AD and it is featured by
the production of proinflammatory cytokines, such as TNF-α, IL-1β,
and IL-6, by activated microglia.19,25 It was shown that Aβ fibrils
can induce excess production of cytokines and neurotoxic
mediators to activate microglia and can injure neurons.26,27 On
the other hand, previous studies demonstrated that chronic
bacterial infections, such as rheumatoid arthritis, leprosy,
tuberculosis, syphilis, and osteomyelitis are often associated with
the deposition of amyloid.28 The bacterial endotoxin LPS is a
major inducer of inflammation and LPS may induce chronic
neuroinflammation, Aβ accumulation/deposition, and impairment
of cognitive function.29 A recent study showed that P. gingivalis
LPS was found at a high frequency in autopsied brain tissues of
patients who died of AD; however, it was not found in normal
human brain tissues.24 It has also shown that P. gingivalis could
enter the brain of ApoE knockout mice.30 For the mechanism of P.
gingivalis entry into the brain, it has been shown that P. gingivalis
has the ability to bind to E-selectin via its OmpA-like protein,31 and
can invade cells by activation of intercellular adhesion molecule
(ICAM)-1 and the small G-protein Rab5 in host cells.32,33 These
lines of evidence suggest that P. gingivalis and its toxin probably
spread by a hematogenous route and are transmitted into the
brain via the blood–brain barrier (BBB). Besides the experiments
using J20 mice, we also performed experiments to examine
memory function, levels of serum cytokines and endotoxin, and
endogenous brain Aβ levels in P. gingivalis-infected WT mice. The
results of the novel objection test showed that cognitive function
was impaired in mice of the P. gingivalis administration group
compared with that in the control mice (Supplementary Fig. 1),
but the brain Aβ level and serum TNF-α, and endotoxin levels
were not different from those in the control group (Supplemen-
tary Figs. 2 and 3). A small amount of TNF-α was also found in the
brain of WT mice, but there was no significant difference between
the P. gingivalis administration group and control group (data not
shown). In this experiment using WT mice, individual differences
among mice were large, and we therefore could not clearly
confirm that the enhancement of brain inflammation was due to
P. gingivalis infection, but we could confirm this tendency.
Therefore, we believe that brain inflammation may be involved
in the mechanisms by which cognitive function declined in the P.
gingivalis-administered WT mice. These results also suggest that
infection with P. gingivalis in WT mice reduces cognitive function
but does not elicit AD-specific pathologies, such as Aβ increase.
These findings suggest that P. gingivalis infection may be related
to exacerbation of AD pathology rather than affecting the onset of
AD. In an in vitro BBB permeability test, it was revealed that LPS
may penetrate the BBB (Supplementary Fig. 4). The results suggest
that J20 mice are more susceptible than WT mice to P. gingivalis
and that inflammation is strongly induced and reflected in the
blood. Inflammatory mediators in the blood enhance BBB
permeability and may penetrate into the brain. Actually, the
increases in inflammatory cytokine levels in the brain in APP-Tg
mice were greater than those in wild-type mice after peripheral
LPS injection.34 In addition, the permeability of the BBB was
increased in APP-Tg mice by the peripherally evoked inflamma-
tion. These inflammatory mediators may activate microglia and
promote Aβ production in cells.35 In addition, the activation of
innate immunity with these factors in brain could affect AD
pathology.36 Therefore, the increased innate immune response in
the brain originating from the intraoral infection of P. ginigvalis
may have exacerbated AD pathology. In the future, we will
examine the detailed mechanism.
Periodontitis is a major cause of loss of teeth. Since there is a
significant correlation between AD and tooth loss, it has been
suggested that periodontitis may be a risk factor for AD.37,38 Tooth
loss reduces chewing function, thereby reducing cerebral blood
flow, and then cognitive function may deteriorate. Oue et al.
reported that cognitive decline was observed in the APP
transgenic mouse from which teeth had been removed, but
deposition of Aβ and induction of brain inflammation were not
observed.39 On the other hand, in this study, we found that APP
transgenic mice that had been infected with P. gingivalis and had
developed periodontal disease showed increased cerebral Aβ
deposition and enhanced intracerebral inflammatory response, as
well as a decrease in cognitive function. These results suggest that
Fig. 4 Concentrations of endotoxin in the brain and serum from P.
gingivalis-infected mice. Levels of endotoxin in the brain and serum
were measured by Limulus assay. Results are expressed as means±
S.D., *p< 0.05, **p< 0.01
Fig. 5 P. gingivalis LPS induces Aβ production in mouse neural cell
cultures. Neural cells isolated from mouse brain were stimulated
with P. gingivalis LPS for 24 h. Amounts of Aβ40 and Aβ42 in the
media were measured by ELISA (n= 3, mean± S.D., *p< 0.05)
Fig. 6 P. gingivalis LPS enhances Aβ-induced cytokine production in
microglia cell cultures. Microglial cells were stimulated with 10 µM
Aβ42 for 6 h and further stimulated with P. gingivalis LPS (0.01, 0.1,
1.0 μg/ml) for 24 h. Amounts of TNF-α and IL-1β in the media were
quantified by ELISA (n= 3, mean± S.D.). **p< 0.01 vs. Aβ 42 alone;
†p< 0.05, ††p< 0.01, vs. LPS alone
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cognitive decline due to periodontal disease and that due to tooth
loss are caused by different molecular mechanisms. Namely, tooth
loss causes memory impairment in an amyloid-independent
manner and is associated with a decreased number of neural
cells in the hippocampus by reduction of BDNF signaling.37 We
also found that chewing dysfunction caused by liquid diet induces
memory impairment and hippocampal neuronal loss due to
impaired BDNF cascade.40
An intervention study to test the efficacy of periodontal
treatment on AD features are needed to conclude that period-
ontitis is truly a risk factor for AD; however, this study suggests a
new possibility that periodontitis directly deteriorate the patho-
logical features of AD. AD is a serious problem in the world;
however, there is still no effective method for the prevention of
AD or a fundamental method for treatment.41 Aβ deposition in the
brain is initiated during the first half of the 40s, more than 15–20
years prior to the onset of cognitive impairment in AD
patients.42,43 It is the period in which patients with periodontal
diseases also begin to increase drastically. Because, periodontal
infections are treatable, treatment of periodontal diseases during




Female hemizygous transgenic (hAPP-J20) and non-transgenic mice (WT)
were obtained from the J20 line, which expresses hAPP containing both
the Swedish and Indiana mutations under the control of a PDGF-β chain
promoter.44 Mice were housed in a pathogen-free facility at a maximum of
five mice per cage until the study began, at which time the mice were
housed individually. The mice were kept on a 12-h light/dark cycle (lights
on at 7:00 am) and, food and water were available ad libitum.45 All mice
were bred and maintained in specific pathogen-free conditions in the
animal facility at Aichigakuin University, and all experiments were
performed in accordance with institutional guidelines of the Animal
Experiment Committee and Gene Recombination Experiment Committee.
Bacteria and culture conditions
Culture of P. gingivalis was performed according to previous reports.31,46
Briefly, P. gingivalis ATCC 33,277 was cultivated with 5% laked rabbit blood-
supplemented brucella HK agar (Kyokuto Pharmaceutical Industrial Co.,
Ltd., Tokyo, Japan) with hemin (2.5 µg/ml), menadione (5 µg/ml), and
dithiothreitol (0.1 mg/ml) and in Trypticase soy broth (BD, Franklin Lakes,
NJ) with yeast extract (2.5 mg/ml), hemin (2.5 µg/ml), menadione (5 µg/ml),
and dithiothreitol (0.1 mg/ml). Bacterial cells were collected, washed, and
suspended in phosphate-buffered saline (PBS). The concentration of
bacteria was determined with a spectrophotometer at an optical density of
660 nm. Live P. gingivalis (109 CFU) was resuspended in 100 µl of PBS with
2.5% carboxymethylcellulose.
Development of periodontitis in mice
A mouse model of periodontitis was established as described previously
with minor modification.46 Briefly, sulfamethoxazole (700 μg/ml) and
trimethoprim (400 μg/ml) in water bottles were given to 62-week-old J20
female mice at any time for 10 days. Three days after the treatment, 109
CFU of live P. gingivalis in 100 µl of PBS with 2.5% carboxymethylcellulose
was applied to the gingival margin of each mouse under brief isoflurane
anesthesia. After inoculation with P. gingivalis, the mice were fasted for 1 h.
PBS containing only 2.5% carboxymethyl cellulose (100 μl) was adminis-
tered to the control group. Five weeks after the oral challenge, a novel
objection test was performed. The mice were then sacrificed, and the sera
and brains were collected. Maxillary specimens were also collected for
micro-CT and histopathological studies.
Evaluation of mandibular bone loss
To evaluate morphological changes in the alveolar bone, the mandibular
alveolar bone was scanned by micro CT (R_mCT AX; Rigaku Corporation,
Tokyo, Japan) in mice 11 weeks after inoculation of P. gingivalis. The
computed tomography was set according to slice thickness (50 μm),
voltage (90 kV), and electrical current (150 µA). Three-dimensional images
were made using TRI/3D Bone (Ratoc, Tokyo, Japan). The distance from the
mesial buccal cement–enamel junction to the alveolar bone crest of the
second molar was measured as a reference for bone height. The
percentage of bone resorption was calculated as the distance from the
mesial buccal cement–enamel junction to the alveolar bone crest divided
by the length of the root × 100.47
Evaluation of cognitive function
The novel objection test was performed on mice to test cognitive memory
as described previously.48 Briefly, in the training session, we placed two
objects in a box (30 cm × 30 cm × 35 cm high). The objects were a white
lamp and a square bottle, the shapes and colors being different but sizes
being almost the same. The mouse was then placed in the box and search
behavior for the two objects was recorded for 10min. We defined a mouse
searching for an object as a mouse facing an object, touching an object, or
performing an action to sniff an object. After 24 h of the training session,
one of the objects used during the training was replaced with a new
object, and the mice were returned to the box. The mice were allowed to
freely search for 3 min. The time spent searching for each object was
recorded, and the duration was evaluated as the degree of cognitive
function.
Evaluation of Aβ deposition in the brain
The mouse brains were soaked in 4% paraformaldehyde at 4 °C for
24 h. After fixation in 4% paraformaldehyde, the brains were then
embedded in paraffin and sectioned at 5 µm. The mandibular bone was
soaked in 4% paraformaldehyde at 4 °C for 48 h. The brain sections were
immunostained using anti-Aβ antibody 82E1 and visualized by the
avidin–biotin–peroxidase complex procedure (Vectastain Elite ABC kit,
Vector Laboratories, Burlingame, Canada) using diaminobenzidine
(ImmPact DAB, Vector Laboratories) as the chromogen. Then the sections
were observed with a microscope (OLYMPUS, Tokyo, Japan). The number
of immunopositive pixels in the hippocampus were counted, and the
values were converted to the area as the amount of Aβ deposition.39
Measurements of Aβ oligomer, TNF-α, and IL-1β in the brain
Human oligomerized Aβ was measured using an ELISA kit purchased from
Wako Pure Chemical Industries, according to the manufacturer’s instruc-
tions. Briefly, the right hemispheres from the brains of transgenic APP/J20
mice treated with or without P. gingivalis were collected and homogenized.
Quantification of total protein was determined using a Micro BCA
protein assay kit and was measured on an absorbance microplate reader
(Molecular Devices, Sunnyval, CA). The homogenates were centrifuged
at 100,000 × g for 20 min at 4 °C. Levels of TNF-α and IL-1β in the
supernatants were measured by ELISA (R&D systems Inc., Minneapolis, MN)
according to the manufacturer’s instructions. Insoluble materials in the
sediments were sonicated in PBS with 6 M guanidine hydrochloride and
were centrifuged at 100,000 × g for 20 min at 4 °C. The supernatant was
then diluted 1:10 before carrying out the sandwich ELISA, which measures
insoluble Aβ oligomer levels, but not amyloid monomers, as detailed in the
manufacturer’s protocol. The final Aβ oligomer values were determined
following normalization of total protein levels.49
Detection of endotoxin in the brain
The endotoxin in mouse serum and brain lysate was measured by a
Limulus assay using an Endospecy ES-50M kit (Seikagaku Co., Tokyo,
Japan).50
Measurement of TNF-α and IL-1β in microglia cultures
A 6-3 microglia cell clone culture kit (Cosmo Bio Co. Ltd., Tokyo, Japan) was
used in this study. The microglial cell line 6-3 (2 × 104 cells/cm2) was
seeded in 96-well culture plates and incubated for 24 h. The cells were
then stimulated with 10 µM Aβ 42 for 6 h and further stimulated with P.
gingivalis-derived LPS (0.01, 0.1, 1.0 µg/ml, LPS-PG from Invitrogen, San
Diego, CA) for 24 h. Levels of TNF-α and IL-1β in the media were measured
using an ELISA kit (R&D Systems) according to the manufacturer’s
instructions.51
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Measurement of Aβ oligomer in murine neuron cultures
Primary neuronal cultures were prepared from the cortices of embryonic
day 17 C57BL/6 mouse embryos.52 Briefly, cortices were dissected and the
meninges were freed. The cortical fragments were incubated with 0.25%
trypsin and 20 µg/ml DNase I in phosphate-buffered saline at 37 °C for 15
min, dissociated into single cells by pipetting, and then resuspended in
serum-free Dulbecco’s modified Eagle’s medium/Ham’s F-12 (Wako Pure
Chemical Industries, Osaka, Japan) supplemented with N2 Supplement
with Transferrin (Wako Pure Chemical Industries, Osaka, Japan) supple-
mented with N2 Supplement with Transferrin (Wako Pure Chemical
Industries, Osaka, Japan).53 Primary neuronal cells were plated in poly-
ethylene-imine-coated 12-well plates at a density of 1 × 106 cells per well.
The neurons were stimulated with or without 0.1, 1, 10 µg/ml of P.
gingivalis-derived LPS for 24 h. Then levels of Aβ40 and Aβ42 in the media
were measured by an ELISA (Wako Pure Chemical Industries).
Statistics
Statistical analyses were performed using an unpaired Student’s t-test.
Multiple comparisons were performed by one-way analysis of variance and
the Bonferroni or Dunn method, with results presented as means ±
standard deviation. P-values less than 0.05 were considered statistically
significant.
Approval of experimental protocol
All experimental protocols were approved by institutional guidelines of the
Aichigakuin University and National Center for Geriatrics and Gerontology.
Data availability
The data that support the findings of this study are available from the
corresponding author upon reasonable request.
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